InsidersTradesSigma
Browse the full record of transactions filed by SHALLCROSS STEVEN A, Chief Executive Officer. Insider active across 1 companies, notably Synthetic Biologics, Inc.. Cumulatively, 2 filings have been logged. Total volume traded: €41k. The latest transaction was disclosed on 10 May 2021 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations
Steven A. Shallcross is the Chief Executive Officer and Chief Financial Officer of Synthetic Biologics, Inc. He oversees the financial and strategic operations of the company, playing an essential role in growth and innovation.